Incidences of Deep Vein Thrombosis and Pulmonary Embolism after Total Knee Arthroplasty Using a Mechanical Compression Device with and without Low-Molecular-Weight Heparin
- PMID: 27595075
- PMCID: PMC5009046
- DOI: 10.5792/ksrr.2016.28.3.213
Incidences of Deep Vein Thrombosis and Pulmonary Embolism after Total Knee Arthroplasty Using a Mechanical Compression Device with and without Low-Molecular-Weight Heparin
Abstract
Purpose: To investigate the incidence of thromboembolic events and complications related to bleeding after total knee arthroplasty (TKA) with a mechanical compression device alone or in combination with low-molecular-weight heparin (LMWH).
Materials and methods: A total of 489 TKA patients (776 knees) were retrospectively reviewed for the incidence of thromboembolic events and complications related to bleeding. While 233 patients (354 knees) were treated with a mechanical compressive device without LMWH, 256 patients (422 knees) were treated with the mechanical compressive device along with LMWH.
Results: The incidences of deep vein thrombosis (DVT) and pulmonary embolism (PE) were 15 of 375 knees (4.0%) and 5 of 375 knees (1.3%), respectively, in the group that used only a mechanical compressive device, and 14 of 401 knees (3.4%) and 5 of 401 knees (1.2%), respectively, in the group that used the mechanical compressive device with LMWH. There was no significant difference between the two groups (p=0.125 and p=0.146, respectively). The postoperative hemovac drainage amount was 635±57 mL in the group with a mechanical compressive device only and 813±84 mL in the group with the device and LMWH; therefore, the amount of drainage was significantly greater in the latter group (p=0.013).
Conclusions: Mechanical compression alone for prophylaxis against DVT and PE after TKA can be an attractive option in Korean patients.
Keywords: Arthroplasty; Intermittent pneumatic compression device; Knee; Mechanical; Prophylaxis; Thromboembolism.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported
References
-
- Parvizi J, Sullivan TA, Trousdale RT, Lewallen DG. Thirty-day mortality after total knee arthroplasty. J Bone Joint Surg Am. 2001;83:1157–1161. - PubMed
-
- Howie C, Hughes H, Watts AC. Venous thromboembolism associated with hip and knee replacement over a tenyear period: a population-based study. J Bone Joint Surg Br. 2005;87:1675–1680. - PubMed
-
- Cohen AT. Long-term benefits of preventing venous thromboembolic events. Curr Med Res Opin. 2012;28:877–889. - PubMed
-
- McRae SJ, Ginsberg JS. Initial treatment of venous thromboembolism. Circulation. 2004;110(9 Suppl 1):I3–I9. - PubMed
-
- Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest. 2009;135:513–520. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources